Special topic section on health economics and public policy of Alzheimer's disease
暂无分享,去创建一个
[1] Adam P Dicker,et al. American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] P. Neumann,et al. The economics of mild cognitive impairment , 2013, Alzheimer's & Dementia.
[3] Nick C Fox,et al. The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease , 2011 .
[4] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[5] L. Schneider,et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society , 2016, The Lancet Neurology.
[6] J. Karlawish,et al. Preference-based quality of life in patients with Alzheimer's disease , 2008, Alzheimer's & Dementia.
[7] J. Mauskopf,et al. A Review of the Methods Used to Estimate the Cost of Alzheimer’s Disease in the United States , 2011, American journal of Alzheimer's disease and other dementias.
[8] G. Ohlin. The Organization for Economic Cooperation and Development , 1968, International Organization.
[9] Linus Jönsson,et al. The Cost of Dementia in Europe , 2012, PharmacoEconomics.
[10] H. Brodaty,et al. ALZHEIMER'S DISEASE INTERNATIONAL , 1997, International journal of geriatric psychiatry.
[11] B. Winblad,et al. Application of Resource Utilization in Dementia (RUD) instrument in a global setting , 2013, Alzheimer's & Dementia.
[12] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[13] T. Trikalinos,et al. Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine. , 2016, JAMA.
[14] Magda Tsolaki,et al. Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review , 2015, Alzheimer's Research & Therapy.
[15] M. Prince,et al. World Alzheimer Report 2015 - The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends , 2015 .
[16] Z. Khachaturian. Editorial: The five-five, ten-ten plan for Alzheimer's disease , 1992, Neurobiology of Aging.
[17] A. Wimo,et al. The Cost of Dementia in Europe A Review of the Evidence , and Methodological Considerations , 2009 .